DocMorris AG ( ZRSEF) - Key Metrics
ZRSEF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $12.19 | -$1.08 | -$0.42 | -$0.43 |
| 2025Q4 | $11.31 | -$1.41 | -$0.63 | -$0.65 |
| 2025Q2 | $18.56 | -$2.11 | -$1.91 | -$1.95 |
| 2024Q4 | $44.16 | -$5.03 | -$1.26 | -$3.64 |
| 2024Q2 | $42.13 | -$3.22 | -$1 | -$1.04 |
ZRSEF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.92 |
| 2025Q4 | 0% | -4.14 |
| 2025Q2 | 0% | -0.99 |
| 2024Q4 | 0% | -1.08 |
| 2024Q2 | 0% | -6.29 |
ZRSEF
Price: $10.24
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.67 USD
Exchange: PNK
Sector: Healthcare
Industry: Pharmaceutical Retailers
Market Capitalization: 500.4 million